Future Healthcare Story

Vaccines Market Current Industry Size and Future Prospective with Key Players, Drivers and Trends

Press release   •   Dec 03, 2019 03:09 EST

According to ARC, the global ​vaccines market size is expected to be worth around Us$ 55.2 billion By 2026, jumping 6.4 percent during 2019 – 2026.

Acumen Research and Consulting’s study on the Vaccines Market, offers in-depth information on the growth drivers and restraints impacting the growth of the market. It studies the potential market trajectory between 2019 and 2026. This market analysis report is compiled to help company’s access relevant information.

It reveals hidden growth opportunities for the market players. In addition to this, the report cautions them against possible threat. It therefore covers unparalleled information on the Vaccines Market derived from trusted industrial sources. The findings included in the report are backed with relevant graphs and statistics. In addition to this, the report includes expert opinions and statistics from leading international organizations. It uses industry-leading analytical tools to offer accurate predictions on the market, which is the most sought-after by key players as they look to establish a strong foothold in the near future.

Download Free Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1599

The report uses quantitative and qualitative analysis on the information obtained. Based on results obtained, it offers refined growth forecasts for the global Vaccines Market. According to the study, the market will witness growth at an accelerated pace in response to the rising demand for novel therapeutics. As a result of increasing prevalence of various illnesses worldwide, governments across the globe are tiring hard and launching several new initiatives to make human resources healthier and fitter than ever. Several countries have ensured access to favourable reimbursement policies, which according to the report, is a chief driver of this market.

In addition to the aforementioned factors, increasing investment towards research and development activities in the pharmaceutical sector is expected to encourage growth in the global market.

Scope of the Report:

The report first uses historic data from different companies. The data collected is used to analyses the growth of industries in the past years. It includes data from the year 2015 to the year 2019. The forecast data provides the reader with an understating of the future of the market. The same data is used to predict the expectation of the companies and how they are expected to evolve in the coming years. The research provides historical as well as estimated data from the year 2019 to 2026. The details in the report give a brief overview of the market by examining its historical data, the current data, and forecast data to understand the growth of the market.

Competitive Landscape

It covers in-depth information on the competitive rivalry witnessed among the leading market players. The report calculates the investment feasibility of this market, which is an indispensable information for potential new entrants. Furthermore, it highlights the most attractive pockets within the global market to help companies plan their investments accordingly. Therefore, for the purpose of the analysis, the report conducts a Porter’s five forces analysis. Through this, it studies the bargaining power suppliers and buyers. The threat to companies from substitutes and new entrants is evaluated as well.

The report dedicates an entire section to discuss the competitive landscape of the market in detail. It studies the growth trajectory of a certain company based on price trend analysis, recent developments, and various other factors.

List of Companies

The report is intended to offer an executive-level blueprint of this market. Therefore, it profiles some of the leading companies operating in the market. Some of the key players in the global Vaccines Market include Astellas Pharma Inc.; Bavarian Nordic; CSL Limited; Daiichi Sankyo Company, Limited; Emergent BioSolutions, Inc.; GlaxoSmithKline plc; Johnson & Johnson; MedImmune, LLC; Merck & Co., Inc.; Mitsubishi Tanabe Pharma Corporation. Over the past few years, the companies have increased their production capacity to meet the growing demand. Companies are expected to focus on new product launches and on consolidating their presence in the coming years.

It conducts SWOT Analysis on the companies to gain insights into the strengths and weaknesses of the companies profiled. The analysis also highlighted the most lucrative opportunities for the companies and challenges that could pose threat in the coming years.

The report evaluated the companies and their market positions in terms of growth strategies they adopted over the years and the impact of the same on the overall Vaccines Market. Furthermore, the report profiled these companies on the basis of the corporate policies, business collaborations, mergers and acquisitions, product portfolio, and recent launches.

Market Segment Analysis:

Acumen Research report focuses on market attractiveness by assessing the key market segments. The report also combines region-wise segments for a better understanding of the supply and demand ratio of the this market. This exclusive study of the report analyzes the present and future market scenario and the industry trends that are influencing the growth of the segments. Besides, the report also covers the value chain analysis, supply chain analysis, and year-on-year basis analysis of the this market.

Market Segmentation

Market By Technology

  • Conjugate Vaccines
  • Inactivated Vaccines
  • Live Attenuated Vaccines,
  • Toxoid Vaccines
  • Recombinant Vaccines

By Indication

  • Dengue
  • DTP
  • Hepatitis
  • HPV
  • Influenza
  • Meningococcal
  • MMR
  • Pneumococcal
  • Polio
  • Rotavirus
  • Varicella

By Type

  • Monovalent
  • Multivalent

By Route of Administration

  • Intramuscular
  • Subcutaneous
  • Oral
  • Others

By Type of Patient

  • Children
  • Adult

Market Regional Analysis:

Based on the regions, the global Vaccines Market is segmented into -North America (US and Canada), Europe (UK, Germany, France, Spain and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of Asia-Pacific), Latin America (Mexico, Brazil and Rest of Latin America), Middle East & Africa (GCC, South Africa and Rest of MEA)

Key Questions Answered in the Report

The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-

  • What is the overall structure of the market?
  • What was the historical value and what is the forecasted value of the market?
  • What are the key product level trends in the market?
  • What are the market level trends in the market?
  • Which of the market players are leading and what are their key differential strategies to retain their stronghold?
  • Which are the most lucrative regions in the market space?

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Vaccine
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Vaccine Market By Technology
1.2.2.1. Global Vaccine Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.2.2. Global Vaccine Market Revenue Share By Technology in 2017
1.2.2.3. Conjugate Vaccines
1.2.2.4. Inactivated Vaccines
1.2.2.5. Live Attenuated Vaccines
1.2.2.6. Toxoid Vaccines
1.2.2.7. Recombinant Vaccines
1.2.3. Vaccine Market By Indication
1.2.3.1. Global Vaccine Market Revenue and Growth Rate Comparison By Indication (2015-2026)
1.2.3.2. Global Vaccine Market Revenue Share By Indication in 2017
1.2.3.3. Dengue
1.2.3.4. DTP
1.2.3.5. Hepatitis
1.2.3.6. HPV
1.2.3.7. Influenza
1.2.3.8. Meningococcal
1.2.3.9. MMR
1.2.3.10. Pneumococcal
1.2.3.11. Polio
1.2.3.12. Rotavirus
1.2.3.13. Varicella
1.2.4. Vaccine Market By Type
1.2.4.1. Global Vaccine Market Revenue and Growth Rate Comparison By Type (2015-2026)
1.2.4.2. Global Vaccine Market Revenue Share By Type in 2017
1.2.4.3. Monovalent
1.2.4.4. Multivalent
1.2.5. Vaccine Market By Route of Administration
1.2.5.1. Global Vaccine Market Revenue and Growth Rate Comparison By Route of Administration (2015-2026)
1.2.5.2. Global Vaccine Market Revenue Share By Route of Administration in 2017
1.2.5.3. Intramuscular
1.2.5.4. Subcutaneous
1.2.5.5. Oral
1.2.5.6. Others
1.2.6. Vaccine Market By Type of Patient
1.2.6.1. Global Vaccine Market Revenue and Growth Rate Comparison By Type of Patient (2015-2026)
1.2.6.2. Global Vaccine Market Revenue Share By Type of Patient in 2017
1.2.6.3. Children
1.2.6.4. Adult
1.2.7. Vaccine Market By Geography
1.2.7.1. Global Vaccine Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.7.2. North America Vaccine Market Revenue and Growth Rate (2015-2026)
1.2.7.3. Europe Vaccine Market Revenue and Growth Rate (2015-2026)
1.2.7.4. Asia-Pacific Vaccine Market Revenue and Growth Rate (2015-2026)
1.2.7.5. Latin America Vaccine Market Revenue and Growth Rate (2015-2026)
1.2.7.6. Middle East and Africa (MEA) Vaccine Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Vaccine Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Vaccine Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Vaccine Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Vaccine Major Manufacturers in 2017

CHAPTER 4. Vaccine Market By Technology
4.1. Global Vaccine Revenue By Technology
4.2. Conjugate Vaccines
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Inactivated Vaccines
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Live Attenuated Vaccines
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Toxoid Vaccines
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Recombinant Vaccines
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. Vaccine Market By Indication
5.1. Global Vaccine Revenue By Indication
5.2. Dengue
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. DTP
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Hepatitis
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. HPV
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.6. Influenza
5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.7. Meningococcal
5.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.8. MMR
5.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.9. Pneumococcal
5.9.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.9.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.10. Polio
5.10.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.10.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.11. Rotavirus
5.11.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.11.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.12. Varicella
5.12.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.12.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. Vaccine Market By Type
6.1. Global Vaccine Revenue By Type
6.2. Monovalent
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Multivalent
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. Vaccine Market By Route of Administration
7.1. Global Vaccine Revenue By Route of Administration
7.2. Intramuscular
7.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.3. Subcutaneous
7.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.4. Oral
7.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.5. Others
7.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 8. Vaccine Market By Type of Patient
8.1. Global Vaccine Revenue By Type of Patient
8.2. Children
8.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
8.3. Adult
8.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 9. North America Vaccine Market By Country
9.1. North America Vaccine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. North America Vaccine Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. U.S.
9.3.1. U.S. Vaccine Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
9.4. Canada
9.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)

CHAPTER 10. Europe Vaccine Market By Country
10.1. Europe Vaccine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Europe Vaccine Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. UK
10.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
10.4. Germany
10.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
10.5. France
10.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
10.6. Spain
10.6.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.6.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
10.7. Rest of Europe
10.7.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.7.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)

CHAPTER 11. Asia-Pacific Vaccine Market By Country
11.1. Asia-Pacific Vaccine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Asia-Pacific Vaccine Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. China
11.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
11.4. Japan
11.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
11.5. India
11.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
11.6. Australia
11.6.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.6.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
11.7. South Korea
11.7.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.7.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
11.8. Rest of Asia-Pacific
11.8.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.8.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)

CHAPTER 12. Latin America Vaccine Market By Country
12.1. Latin America Vaccine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Latin America Vaccine Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. Brazil
12.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
12.4. Mexico
12.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
12.5. Rest of Latin America
12.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)

CHAPTER 13. MIDDLE EAST & AFRICA VACCINE MARKET BY COUNTRY
13.1. Middle East & Africa Vaccine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
13.2. Middle East & Africa Vaccine Market Revenue Share Comparison, 2015 & 2026 (%)
13.3. GCC
13.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
13.3.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
13.4. South Africa
13.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
13.4.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
13.5. Rest of Middle East & Africa
13.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
13.5.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)

CHAPTER 14. COMPANY PROFILE
14.1. Astellas Pharma Inc.
14.1.1. Company Snapshot
14.1.2. Overview
14.1.3. Financial Overview
14.1.4. Product Portfolio
14.1.5. Key Developments
14.1.6. Strategies
14.2. Bavarian Nordic
14.2.1. Company Snapshot
14.2.2. Overview
14.2.3. Financial Overview
14.2.4. Product Portfolio
14.2.5. Key Developments
14.2.6. Strategies
14.3. CSL Limited
14.3.1. Company Snapshot
14.3.2. Overview
14.3.3. Financial Overview
14.3.4. Product Portfolio
14.3.5. Key Developments
14.3.6. Strategies
14.4. Daiichi Sankyo Company, Limited
14.4.1. Company Snapshot
14.4.2. Overview
14.4.3. Financial Overview
14.4.4. Product Portfolio
14.4.5. Key Developments
14.4.6. Strategies
14.5. Emergent BioSolutions, Inc.
14.5.1. Company Snapshot
14.5.2. Overview
14.5.3. Financial Overview
14.5.4. Product Portfolio
14.5.5. Key Developments
14.5.6. Strategies
14.6. GlaxoSmithKline plc
14.6.1. Company Snapshot
14.6.2. Overview
14.6.3. Financial Overview
14.6.4. Product Portfolio
14.6.5. Key Developments
14.6.6. Strategies
14.7. Johnson & Johnson
14.7.1. Company Snapshot
14.7.2. Overview
14.7.3. Financial Overview
14.7.4. Product Portfolio
14.7.5. Key Developments
14.7.6. Strategies
14.8. MedImmune, LLC
14.8.1. Company Snapshot
14.8.2. Overview
14.8.3. Financial Overview
14.8.4. Product Portfolio
14.8.5. Key Developments
14.8.6. Strategies
14.9. Merck & Co., Inc.
14.9.1. Company Snapshot
14.9.2. Overview
14.9.3. Financial Overview
14.9.4. Product Portfolio
14.9.5. Key Developments
14.9.6. Strategies
14.10. Mitsubishi Tanabe Pharma Corporation
14.10.1. Company Snapshot
14.10.2. Overview
14.10.3. Financial Overview
14.10.4. Product Portfolio
14.10.5. Key Developments
14.10.6. Strategies
14.11. Others
14.11.1. Company Snapshot
14.11.2. Overview
14.11.3. Financial Overview
14.11.4. Product Portfolio
14.11.5. Key Developments
14.11.6. Strategies

CHAPTER 15. RESEARCH APPROACH
15.1. Research Methodology
15.1.1. Initial Data Search
15.1.2. Secondary Research
15.1.3. Primary Research
15.2. Assumptions and Scope

The report is readily available and can be dispatched immediately after payment confirmation.

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/request-sample/1599

Contact Us:

Acumen Research and Consulting

Email: sales@acumenresearchandconsulting.com

Phone: +1 407 915 4157

Latest Healthcare industry news and articles